CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST

CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST logo
🇬🇧United Kingdom
Ownership
Subsidiary
Established
1992-11-04
Employees
10K
Market Cap
-
Website
http://www.cuh.org.uk
Clinical Trials
Related News

Anti IL-18 (GSK1070806) in Behcet's Disease

Phase 2
Conditions
Behcet's Disease
First Posted Date
2018-05-11
Last Posted Date
2018-05-11
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Target Recruit Count
12
Registration Number
NCT03522662
Locations
🇬🇧

Addenbrooke's Hospital, University of Cambridge NHS Foundation Trust, Cambridge, United Kingdom

Acquired Immunodeficiency in ANCA Associated Vasculitis

First Posted Date
2018-05-03
Last Posted Date
2018-05-03
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Target Recruit Count
124
Registration Number
NCT03514979

A Series of Pilot Studies to Evaluate the haemoDynamic and mEtabolic Effects oF apelIn aNd rElaxin

First Posted Date
2018-02-28
Last Posted Date
2024-02-07
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Target Recruit Count
170
Registration Number
NCT03449251
Locations
🇬🇧

Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom

Differential Metabolic Signature of Stroke Patients Undergoing Thrombolysis

Completed
Conditions
Stroke, Ischemic
First Posted Date
2018-02-23
Last Posted Date
2023-02-08
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Target Recruit Count
68
Registration Number
NCT03443245
Locations
🇬🇧

Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

Patient Agenda Setting and Clinic Efficiency in Outpatients

Not Applicable
Completed
Conditions
Respiratory Tract Diseases
Interventions
Other: Patient agenda form
First Posted Date
2018-02-15
Last Posted Date
2018-02-15
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Target Recruit Count
165
Registration Number
NCT03433729
Locations
🇬🇧

Cambridge University Hospitals NHS Foundation Trust, Cambridge, Cambridgeshire, United Kingdom

Nicotinamide Riboside and Mitochondrial Biogenesis

First Posted Date
2018-02-14
Last Posted Date
2023-07-20
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Target Recruit Count
13
Registration Number
NCT03432871
Locations
🇬🇧

Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom

Assessment of BladderLight SurvEILlance

Phase 2
Conditions
Bladder Cancer
Interventions
Device: BladderLight®
First Posted Date
2018-02-09
Last Posted Date
2018-02-09
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Target Recruit Count
2100
Registration Number
NCT03427034

Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease

First Posted Date
2017-11-28
Last Posted Date
2021-07-23
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Target Recruit Count
60
Registration Number
NCT03355027
Locations
🇬🇧

Addenbrooke's Hospital, Cambridge, Cambridgeshire, United Kingdom

Continuous vs Intermittent Dabrafenib Plus Trametinib in BRAFV600 Mutant Stage 3 Unresectable or Metastatic Melanoma

Phase 2
Completed
Conditions
Melanoma
Interventions
Drug: Dabrafenib
Drug: Trametinib
First Posted Date
2017-11-24
Last Posted Date
2020-12-08
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Target Recruit Count
79
Registration Number
NCT03352947
Locations
🇬🇧

Addenbrooke's Hospital, Cambridge, England, United Kingdom

Capture of Prostatic Trans-rectal Ultrasound Scans for Research

First Posted Date
2017-10-26
Last Posted Date
2020-07-10
Lead Sponsor
Cambridge University Hospitals NHS Foundation Trust
Target Recruit Count
150
Registration Number
NCT03321864
Locations
🇬🇧

Addenbrookes Hospital, Cambridge, Cambridgeshire, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy